Disclosure and Transfer Sample Clauses
The Disclosure and Transfer clause governs how information or assets are shared and transferred between parties under an agreement. It typically outlines the circumstances under which confidential or proprietary information may be disclosed, and the procedures for transferring ownership or rights to certain materials, data, or property. For example, it may specify what information must be provided during due diligence or how intellectual property is handed over at the end of a contract. The core function of this clause is to ensure transparency and proper handling of sensitive information or assets, thereby reducing misunderstandings and protecting the interests of all parties involved.
Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory authorities across the world. The Institution will ensure that all necessary consents are in place to comply with the provisions of this Section 6 with respect to any affected employees and contractors of Institution and shall execute the EU standard contractual clauses on a controller-to-controller basis that are attached as Attachment E. Principal Investigator will ensure
Disclosure and Transfer. OF Marina KNOW-HOW AND COOPERATION
Disclosure and Transfer. Ferring shall share with I-MAB or any of its designees, as reasonably requested by I-MAB, the Regulatory Documentation in Ferrings’s control with respect to the Licensed Compound and the Licensed Product within sixty (60) days after the Effective Date.
Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory 6.4 Sdělování a přenos informací. Některé Osobní údaje, jimiž se zabývá článek 6 této Smlouvy, mohou být sděleny nebo předány jiným členům CRO nebo skupiny společností Pfizer, zástupcům a dodavatelům pracujícím jménem CRO nebo authorities across the world. The skupiny Pfizer a zahraničním Institution will ensure that all kontrolním úřadům. Zdravotnické necessary consents according to zařízení zajistí získání veškerých templates made available by the nezbytných souhlasů podle vzorů CRO and agreed with Pfizer with dostupných CRO a odsouhlasených respect to Pfizer’s uses, are in place společností Pfizer s ohledem na to carry out the data disclosures set použití společnosti Pfizer, jsou out under the provisions of this zavedeny k provedení zveřejnění Section 6 with respect to any údajů, aby bylo vyhověno affected employees and contractors ujednáním článku 6 této Smlouvy of Institution and shall execute the ve vztahu ke všem dotčeným EU standard contractual clauses on zaměstnancům nebo dodavatelům a controller-to-controller basis that zdravotnického zařízení a bude are attached as Attachment D. vykonávat standardní smluvní Principal Investigator will ensure ustanovení EU na bázi správce- such consent for any individuals správci, jak je uvedeno v Příloze D. working under Principal Hlavní zkoušející zajistí takový Investigator’s direction and control souhlas pro všechny jednotlivce who are not employees or pracující pod vedením a kontrolou contractors of Institution. Hlavního zkoušejícího, kteří nejsou zaměstnanci nebo dodavateli zdravotnického zařízení.
Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory authorities
Disclosure and Transfer. FBFC shall promptly upon the written request of ORTHOVITA supply and transfer to ORTHOVITA technical documentation and KNOW-HOW in the following sequence : - At any time within a one year period from the EFFECTIVE DATE, supply of the technical documentation relating to the KNOW-HOW and implementation of the PROCESS by ORTHOVITA. - At any time within a two year period from the EFFECTIVE DATE, sequential delivery of results or medical protocols on human and animal implantations performed under contract with the K.U. LEUVEN either at the K.U. LEUVEN or in other medical centers under its scientific supervision. - Subject to the performance by ORTHOVITA of its payment obligations as provided for in Articles 4 and 5, assignment of all FBFC's property rights on the patents described in appendix 2.
Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory authorities across the world. The Health Services Provider will ensure that all necessary consents according to templates made available by the CRO and agreed with Pfizer with respect to Pfizer’s uses, are in place to carry out the data disclosures set out under the provisions of this Section 6 with respect to any affected employees or contractors of the The Health Services Provider.
Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory authorities across the world. The Institution will help ensure that all necessary consents are in place to comply with the provisions of this Section 6 with respect to any affected study personnel and shall execute the EU standard contractual clauses on a controller-to-controller basis that are attached as Attachment L. 6.4 Sdělování a přenos. Některé osobní údaje, jimiž se zabývá tento článek 6, mohou být sděleny nebo předány jiným členům CRO nebo skupiny společností Pfizer, zástupcům a dodavatelům pracujícím jménem CRO nebo skupiny Pfizer a kontrolním úřadům po celém světě. Zdravotnické zařízení pomůže zajistit získání veškerých nezbytných souhlasů, aby bylo vyhověno ujednáním tohoto článku 6 ve vztahu ke všem dotčeným pracovníkům klinického hodnocení a bude plnit standardní smluvní doložky EU na bázi správce-správci, která je uvedena jako příloha L.